<SEC-DOCUMENT>0001193125-22-019895.txt : 20220127
<SEC-HEADER>0001193125-22-019895.hdr.sgml : 20220127
<ACCEPTANCE-DATETIME>20220127165304
ACCESSION NUMBER:		0001193125-22-019895
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20220127
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220127
DATE AS OF CHANGE:		20220127

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Bausch Health Companies Inc.
		CENTRAL INDEX KEY:			0000885590
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			NJ
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-14956
		FILM NUMBER:		22563843

	BUSINESS ADDRESS:	
		STREET 1:		2150 ST. ELZEAR BLVD. WEST
		STREET 2:		LAVAL
		CITY:			QUEBEC
		STATE:			A8
		ZIP:			H7L 4A8
		BUSINESS PHONE:		514-744-6792

	MAIL ADDRESS:	
		STREET 1:		2150 ST. ELZEAR BLVD. WEST
		STREET 2:		LAVAL
		CITY:			QUEBEC
		STATE:			A8
		ZIP:			H7L 4A8

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Valeant Pharmaceuticals International, Inc.
		DATE OF NAME CHANGE:	20100928

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BIOVAIL Corp
		DATE OF NAME CHANGE:	20100416

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BIOVAIL CORP INTERNATIONAL
		DATE OF NAME CHANGE:	19960522
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d291411d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:bhc="http://www.bauschhealth.com/20220127" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey_duration_2022-01-27_to_2022-01-27" name="dei:EntityCentralIndexKey" contextRef="duration_2022-01-27_to_2022-01-27">0000885590</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_AmendmentFlag_duration_2022-01-27_to_2022-01-27" name="dei:AmendmentFlag" contextRef="duration_2022-01-27_to_2022-01-27">false</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="bhc-20220127.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2022-01-27_to_2022-01-27"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885590</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-27</xbrli:startDate> <xbrli:endDate>2022-01-27</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <ix:nonNumeric name="dei:DocumentType" contextRef="duration_2022-01-27_to_2022-01-27">8-K</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section 13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of the earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2022-01-27_to_2022-01-27" format="ixt:date-monthname-day-year-en">January 27, 2022</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric contextRef="duration_2022-01-27_to_2022-01-27" name="dei:EntityRegistrantName">Bausch Health Companies Inc.</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact Name of Registrant as Specified in Its Charter)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric contextRef="duration_2022-01-27_to_2022-01-27" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:edgarprovcountryen">British Columbia</ix:nonNumeric>, Canada</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric contextRef="duration_2022-01-27_to_2022-01-27" name="dei:EntityFileNumber">001-14956</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric contextRef="duration_2022-01-27_to_2022-01-27" name="dei:EntityTaxIdentificationNumber">98-0448205</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or Other Jurisdiction of</p><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Incorporation or Organization)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(I.R.S. Employer</p><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification Number)</p></td></tr> </table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric contextRef="duration_2022-01-27_to_2022-01-27" name="dei:EntityAddressAddressLine1">2150 St. Elz&#233;ar Blvd. West</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric contextRef="duration_2022-01-27_to_2022-01-27" name="dei:EntityAddressCityOrTown">Laval</ix:nonNumeric>, <ix:nonNumeric contextRef="duration_2022-01-27_to_2022-01-27" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen">Quebec</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCountry" contextRef="duration_2022-01-27_to_2022-01-27" format="ixt-sec:countrynameen">Canada</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2022-01-27_to_2022-01-27">H7L&#160;4A8</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Address of Principal Executive Offices)(Zip Code)</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2022-01-27_to_2022-01-27">514</ix:nonNumeric>-<ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2022-01-27_to_2022-01-27">744-6792</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Registrant&#8217;s telephone number, including area code)</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name or former address, if changed since last report)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric contextRef="duration_2022-01-27_to_2022-01-27" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr> </table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric contextRef="duration_2022-01-27_to_2022-01-27" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p></td></tr> </table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric contextRef="duration_2022-01-27_to_2022-01-27" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p></td></tr> </table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric contextRef="duration_2022-01-27_to_2022-01-27" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p></td></tr> </table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section 12(b) of the Act:</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2022-01-27_to_2022-01-27">Common Shares, No Par Value</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2022-01-27_to_2022-01-27">BHC</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2022-01-27_to_2022-01-27" format="ixt-sec:exchnameen">New York Stock Exchange</ix:nonNumeric>, Toronto Stock Exchange</span></td></tr> </table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">Emerging growth company <ix:nonNumeric contextRef="duration_2022-01-27_to_2022-01-27" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div> <p style='page-break-before:always'></p> <hr style="color:#999999;height:3px;width:100%" /> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item&#160;8.01 Other Events.</p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Secured Notes Offering </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On January&#160;27, 2022, Bausch Health Companies Inc. (the &#8220;Company&#8221;) announced that it launched and priced an offering of $1.0&#160;billion aggregate principal amount of new senior secured notes due 2027 (the &#8220;Notes&#8221;). The Notes will bear interest at a rate of 6.125% per year, and the offering price for the Notes was 100.000% of the principal amount thereof. The Notes will be offered in the United States to qualified institutional investors pursuant to Rule 144A under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and outside the United States to <span style="white-space:nowrap">non-U.S.</span> persons pursuant to Regulation S under the Securities Act.</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Closing of the Notes offering will not be conditioned upon completion of the initial public offering (&#8220;IPO&#8221;) of Bausch + Lomb Corporation (&#8220;Bausch + Lomb&#8221; and such offering, the &#8220;Bausch + Lomb IPO&#8221;), but if the Bausch + Lomb IPO does not occur on or prior to August&#160;15, 2022, the Company will be required to redeem the Notes at such time at a redemption price equal to the issue price of the Notes plus accrued and unpaid interest.</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company also issued press releases pursuant to Rule 135c under the Securities Act relating to the offering of the Notes. In accordance with Rule 135c(d) under the Securities Act, copies of the press releases are attached hereto as Exhibits 99.1 and 99.2 to this Current Report on Form <span style="white-space:nowrap">8-K,</span> which are incorporated herein by reference.</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing is qualified by reference to the press releases that are attached as Exhibits 99.1 and 99.2 to this Current Report on Form <span style="white-space:nowrap">8-K,</span> which are incorporated herein by reference.</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Current Report on Form <span style="white-space:nowrap">8-K</span> and the press releases attached hereto as Exhibits 99.1 and 99.2 do not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any offer, solicitation or sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. These securities will not be registered under the Securities Act or any state securities laws and, unless so registered, may not be offered or sold in the United States except pursuant to an exemption from the registration requirements of the Securities Act and applicable state securities laws. The Notes have not been and will not be qualified for sale to the public by prospectus under applicable Canadian securities laws and, accordingly, any offer and sale of the securities in Canada will be made on a basis which is exempt from the prospectus requirements of such securities laws.</p></div></div> <p style='page-break-before:always'></p> <hr style="color:#999999;height:3px;width:100%" /> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item&#160;9.01 Financial Statements and Exhibits</p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Exhibits</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td></td>
<td style="vertical-align:bottom;width:5%"></td>
<td style="width:92%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">Exhibit<br />Number</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Description</p></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d291411dex991.htm">Press release announcing the launch of the Notes offering, dated January&#160;27, 2022 </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d291411dex992.htm">Press release announcing the pricing of the Notes offering, dated January&#160;27, 2022 </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">The cover page from this Current Report on Form <span style="white-space:nowrap">8-K,</span> formatted in Inline XBRL.</td></tr></table></div></div> <p style='page-break-before:always'></p> <hr style="color:#999999;height:3px;width:100%" /> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Signatures</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:40%;border:0;margin-left:auto">
<tr>
<td style="width:7%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:12%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:79%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top" colspan="5"><span style="font-weight:bold">BAUSCH HEALTH COMPANIES INC.</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="4"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="3" style="vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Sam Eldessouky</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;white-space:nowrap">Name:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">Sam Eldessouky</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;white-space:nowrap">Title:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">Executive Vice President, Chief Financial Officer</td></tr></table></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: January&#160;27, 2022</p></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d291411dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g291411g61r84.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="75%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Investor Contact:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><B>Media Contact:</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Arthur Shannon</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Lainie Keller</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><U>arthur.shannon@bauschhealth.com</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><U>lainie.keller@bauschhealth.com</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">(514) <FONT STYLE="white-space:nowrap">856-3855</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">(908) <FONT STYLE="white-space:nowrap">927-1198</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">(877) <FONT STYLE="white-space:nowrap">281-6642</FONT> (toll free)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>BAUSCH HEALTH ANNOUNCES LAUNCH OF PRIVATE OFFERING OF SENIOR SECURED NOTES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">LAVAL, Quebec, Jan. 27, 2022 &#151; Bausch Health Companies Inc. (NYSE/TSX: BHC) (&#147;Bausch Health&#148; or the &#147;Company&#148;) announced today that
it has launched an offering of $1.0&nbsp;billion aggregate principal amount of new senior secured notes due 2027 (the &#147;Notes&#148;). As previously announced, the Company is also seeking to refinance its existing credit agreement (the
&#147;Credit Agreement&#148; and such refinancing, the &#147;Credit Agreement Refinancing&#148;). The refinanced Credit Agreement is expected to consist of approximately $2.5&nbsp;billion of term B loans (the &#147;New Term B Loans&#148;) and a
$975&nbsp;million revolving credit facility. The Credit Agreement Refinancing is expected to occur upon completion of the initial public offering (&#147;IPO&#148;) of Bausch + Lomb Corporation (&#147;Bausch + Lomb&#148; and such offering, the
&#147;Bausch + Lomb IPO&#148;) and a related debt financing by Bausch + Lomb (the &#147;Bausch + Lomb Debt Financing&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The proceeds from the
offering of the Notes, along with the expected proceeds from the New Term B Loans, the Bausch + Lomb IPO and the repayment of an intercompany note owed to us by Bausch + Lomb (which repayment is expected to be funded by the Bausch + Lomb Debt
Financing), are expected to be used to fund the Company&#146;s previously announced conditional redemption in full of its outstanding 6.125% Senior Notes due 2025 (the &#147;6.125% Notes due 2025&#148;), refinance all of the existing Term B Loans,
fund the Company&#146;s previously announced conditional partial redemption of its outstanding 9.000% Senior Notes due 2025 (the &#147;9.000% Notes due 2025 and, collectively with the 6.125% Senior Notes due 2025, the &#147;Existing Notes&#148;) and
to pay related fees, premiums and expenses. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Notes will be guaranteed by each of the Company&#146;s subsidiaries that are guarantors under the Credit
Agreement and existing senior notes and will be secured on a first priority basis by liens on the assets that secure the Credit Agreement and existing senior secured notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Notes will not be registered under the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), or any state securities law and may not be
offered or sold in the United States absent registration or an applicable exemption from registration under the Securities Act and applicable state securities laws. The Notes will be offered in the United States only to persons reasonably believed
to be qualified institutional buyers pursuant to Rule 144A under the Securities Act and outside the United States to <FONT STYLE="white-space:nowrap">non-U.S.</FONT> persons pursuant to Regulation S under the Securities Act. The Notes have not been
and will not be qualified for sale to the public by prospectus under applicable Canadian securities laws and, accordingly, any offer and sale of the Notes in Canada will be made on a basis, which is exempt from the prospectus requirements of such
securities laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The redemption of the 6.125% Notes due 2025 is conditioned upon the completion of the Credit Agreement Refinancing (the &#147;6.125%
Notes Condition&#148;). The Company intends to discharge the indenture governing the 6.125% Notes due 2025 concurrently with satisfying such 6.125% Notes Condition. The partial redemption of the 9.000% Notes due 2025 is conditioned upon the receipt
of </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
aggregate gross proceeds from the Bausch + Lomb IPO, the Bausch + Lomb Debt Financing, the Credit Agreement Refinancing and the offering of the Notes of at least $7.0&nbsp;billion (the
&#147;9.000% Notes Condition&#148; and, together with the 6.125% Notes Condition, the &#147;Conditions&#148;). This announcement does not constitute an offer to purchase or the solicitation of an offer to sell the Existing Notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing transactions are subject to market and other conditions and are anticipated to close in the first quarter of 2022. However, there can be no
assurance that the Company will be able to successfully complete the transactions, on the terms described above, or at all. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This news release is being
issued pursuant to Rule 135c under the Securities Act and shall not constitute an offer to sell or the solicitation of an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any
jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Bausch Health </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Bausch Health Companies Inc.
(NYSE/TSX: BHC) is a global company whose mission is to improve people&#146;s lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">over-the-counter</FONT></FONT> products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing
global health. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-looking Statements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This news
release may contain forward-looking statements, including, but not limited to, our financing plans and the details thereof, including the proposed use of proceeds therefrom, whether the Conditions to the redemption of the Existing Notes will occur,
the expected timing of the Credit Agreement Refinancing (including the New Term B Loans) and our ability to close such transaction, the offering of the Notes and the details thereof, the other expected effects of the Credit Agreement Refinancing,
the timing expectations of the Bausch + Lomb IPO, the Bausch + Lomb Debt Financing, the IPO of our Solta aesthetic medical device business through Solta Medical Corporation and the Company&#146;s plan to spinoff or separate its eye health business
from the remainder of Bausch Health, subject to market conditions and regulatory, stock exchange and other necessary approvals, that the spinoff will occur following the expiry of customary <FONT STYLE="white-space:nowrap">lock-ups</FONT> and the
achievement of our target net leverage ratios, subject to receipt of shareholder and necessary approvals, the capitalization structure of such transaction, the anticipated <FONT STYLE="white-space:nowrap">dis-synergies</FONT> resulting from such
transaction (including the allocation thereof between the separated entity and the remainder of Bausch Health) and the Company&#146;s plans and expectations for 2022 and beyond. Forward-looking statements may generally be identified by the use of
the words &#147;anticipates,&#148; &#147;expects,&#148; &#147;predicts,&#148; &#147;goals,&#148; &#147;intends,&#148; &#147;plans,&#148; &#147;should,&#148; &#147;could,&#148; &#147;would,&#148; &#147;may,&#148; &#147;will,&#148;
&#147;believes,&#148; &#147;estimates,&#148; &#147;potential,&#148; &#147;target,&#148; &#147;commit,&#148; &#147;forecast,&#148; &#147;tracking,&#148; or &#147;continue&#148; and variations or similar expressions, and phrases or statements that
certain actions, events or results may, could, should or will be achieved, received or taken or will occur or result, and similar such expressions also identify forward-looking information. These forward-looking statements are based upon the current
expectations and beliefs of management and are provided for the purpose of providing additional information about such expectations and beliefs and readers are cautioned that these statements may not be appropriate for other purposes. These
forward-looking statements are subject to certain risks and uncertainties that could cause actual results and events to differ materially from those described in these forward-looking statements. These risks and uncertainties include, but are </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2 </B><B>|</B> Page </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
not limited to, the risks and uncertainties discussed in the Company&#146;s most recent annual and quarterly reports and detailed from time to time in the Company&#146;s other filings with
the&nbsp;U.S.&nbsp;Securities and Exchange Commission, including those identified in Bausch + Lomb&#146;s filings relating to the Bausch + Lomb IPO, and the Canadian Securities Administrators, which risks and uncertainties are incorporated herein by
reference. They also include, but are not limited to, risks and uncertainties caused by or relating to the evolving <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic, the fear of that pandemic, the availability and effectiveness of vaccines
for <FONT STYLE="white-space:nowrap">COVID-19</FONT> (including with respect to current or future variants), <FONT STYLE="white-space:nowrap">COVID-19</FONT> vaccine immunization rates, new lockdowns in certain countries the emergence of variant
strains of <FONT STYLE="white-space:nowrap">COVID-19</FONT> and the potential effects of that pandemic, the severity, duration and future impact of which are highly uncertain and cannot be predicted, and which may have a material adverse impact on
the Company, including but not limited to its supply chain, third-party suppliers, project development timelines, employee base, liquidity, stock price, financial condition and costs (which may increase) and revenue and margins (both of which may
decrease). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Readers are cautioned not to place undue reliance on any of these forward-looking statements. These forward-looking statements speak only as
of the date hereof. Bausch Health undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this news release or to reflect actual outcomes, unless required by law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">### </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>3 </B><B>|</B> Page </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>d291411dex992.htm
<DESCRIPTION>EX-99.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.2 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g291411g61r84.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="75%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Investor Contact:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><B>Media Contact:</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Arthur Shannon</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Lainie Keller</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><U>arthur.shannon@bauschhealth.com</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><U>lainie.keller@bauschhealth.com</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">(514) <FONT STYLE="white-space:nowrap">856-3855</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">(908) <FONT STYLE="white-space:nowrap">927-1198</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">(877) <FONT STYLE="white-space:nowrap">281-6642</FONT> (toll free)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>BAUSCH HEALTH ANNOUNCES PRICING OF PRIVATE OFFERING OF SENIOR SECURED NOTES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">LAVAL, Quebec, Jan. 27, 2022 &#151; Bausch Health Companies Inc. (NYSE/TSX: BHC) (&#147;Bausch Health&#148; or the &#147;Company&#148;) announced today that
it has priced its previously announced offering of $1.0&nbsp;billion aggregate principal amount of 6.125% senior secured notes due 2027 (the &#147;Notes&#148;). The Notes will be sold to investors at a price of 100.000% of the principal amount
thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As previously announced, the Company is also seeking to refinance its existing credit agreement (the &#147;Credit Agreement&#148; and such
refinancing, the &#147;Credit Agreement Refinancing&#148;). The refinanced Credit Agreement is expected to consist of approximately $2.5&nbsp;billion of term B loans (the &#147;New Term B Loans&#148;) and a $975&nbsp;million revolving credit
facility. The Credit Agreement Refinancing is expected to occur upon completion of the initial public offering (&#147;IPO&#148;) of Bausch + Lomb Corporation (&#147;Bausch + Lomb&#148; and such offering, the &#147;Bausch + Lomb IPO&#148;) and a
related debt financing by Bausch + Lomb (the &#147;Bausch + Lomb Debt Financing&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The proceeds from the offering of the Notes, along with the
expected proceeds from the New Term B Loans, the Bausch + Lomb IPO and the repayment of an intercompany note owed to us by Bausch + Lomb (which repayment is expected to be funded by the Bausch + Lomb Debt Financing), are expected to be used to fund
the Company&#146;s previously announced conditional redemption in full of its outstanding 6.125% Senior Notes due 2025 (the &#147;6.125% Notes due 2025&#148;), refinance all of the existing Term B Loans, fund the Company&#146;s previously announced
conditional partial redemption of its outstanding 9.000% Senior Notes due 2025 (the &#147;9.000% Notes due 2025 and, collectively with the 6.125% Senior Notes due 2025, the &#147;Existing Notes&#148;) and to pay related fees, premiums and expenses.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Notes will be guaranteed by each of the Company&#146;s subsidiaries that are guarantors under the Credit Agreement and existing senior notes and will
be secured on a first priority basis by liens on the assets that secure the Credit Agreement and existing senior secured notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Notes will not be
registered under the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), or any state securities law and may not be offered or sold in the United States absent registration or an applicable exemption from registration under the
Securities Act and applicable state securities laws. The Notes will be offered in the United States only to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act and outside the United States
to <FONT STYLE="white-space:nowrap">non-U.S.</FONT> persons pursuant to Regulation S under the Securities Act. The Notes have not been and will not be qualified for sale to the public by prospectus under applicable Canadian securities laws and,
accordingly, any offer and sale of the Notes in Canada will be made on a basis, which is exempt from the prospectus requirements of such securities laws. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The redemption of the 6.125% Notes due 2025 is conditioned upon the completion of the Credit Agreement
Refinancing (the &#147;6.125% Notes Condition&#148;). The Company intends to discharge the indenture governing the 6.125% Notes due 2025 concurrently with satisfying such 6.125% Notes Condition. The partial redemption of the 9.000% Notes due 2025 is
conditioned upon the receipt of aggregate gross proceeds from the Bausch + Lomb IPO, the Bausch + Lomb Debt Financing, the Credit Agreement Refinancing and the offering of the Notes of at least $7.0&nbsp;billion (the &#147;9.000% Notes
Condition&#148; and, together with the 6.125% Notes Condition, the &#147;Conditions&#148;). This announcement does not constitute an offer to purchase or the solicitation of an offer to sell the Existing Notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This news release is being issued pursuant to Rule 135c under the Securities Act and shall not constitute an offer to sell or the solicitation of an offer to
sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of
any such jurisdiction. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Bausch Health </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Bausch
Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people&#146;s lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. We are delivering on our commitments as we build an
innovative company dedicated to advancing global health. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-looking Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This news release may contain forward-looking statements, including, but not limited to, our financing plans and the details thereof, including the proposed
use of proceeds therefrom, whether the Conditions to the redemption of the Existing Notes will occur, the expected timing of the Credit Agreement Refinancing (including the New Term B Loans) and our ability to close such transaction, the offering of
the Notes and the details thereof, and our ability to close such offering, the other expected effects of the Credit Agreement Refinancing, the timing expectations of the Bausch + Lomb IPO, the Bausch + Lomb Debt Financing, the IPO of our Solta
aesthetic medical device business through Solta Medical Corporation and the Company&#146;s plan to spinoff or separate its eye health business from the remainder of Bausch Health, subject to market conditions and regulatory, stock exchange and other
necessary approvals, that the spinoff will occur following the expiry of customary <FONT STYLE="white-space:nowrap">lock-ups</FONT> and the achievement of our target net leverage ratios, subject to receipt of shareholder and necessary approvals, the
capitalization structure of such transaction, the anticipated <FONT STYLE="white-space:nowrap">dis-synergies</FONT> resulting from such transaction (including the allocation thereof between the separated entity and the remainder of Bausch Health)
and the Company&#146;s plans and expectations for 2022 and beyond. Forward-looking statements may generally be identified by the use of the words &#147;anticipates,&#148; &#147;expects,&#148; &#147;predicts,&#148; &#147;goals,&#148;
&#147;intends,&#148; &#147;plans,&#148; &#147;should,&#148; &#147;could,&#148; &#147;would,&#148; &#147;may,&#148; &#147;will,&#148; &#147;believes,&#148; &#147;estimates,&#148; &#147;potential,&#148; &#147;target,&#148; &#147;commit,&#148;
&#147;forecast,&#148; &#147;tracking,&#148; or &#147;continue&#148; and variations or similar expressions, and phrases or statements that certain actions, events or results may, could, should or will be achieved, received or taken or will occur or
result, and similar such expressions also identify forward-looking information. These forward-looking statements are based upon the current expectations and beliefs of management and are provided for the purpose of providing additional information
about such expectations and beliefs and readers are cautioned that these statements may not be appropriate for other purposes. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results and events
to differ materially from those described in these forward-looking </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2 |</B> Page </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
statements. These risks and uncertainties include, but are not limited to, the risks and uncertainties discussed in the Company&#146;s most recent annual and quarterly reports and detailed from
time to time in the Company&#146;s other filings with the&nbsp;U.S.&nbsp;Securities and Exchange Commission, including those identified in Bausch + Lomb&#146;s filings relating to the Bausch + Lomb IPO, and the Canadian Securities Administrators,
which risks and uncertainties are incorporated herein by reference. They also include, but are not limited to, risks and uncertainties caused by or relating to the evolving <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic, the fear of that
pandemic, the availability and effectiveness of vaccines for <FONT STYLE="white-space:nowrap">COVID-19</FONT> (including with respect to current or future variants), <FONT STYLE="white-space:nowrap">COVID-19</FONT> vaccine immunization rates, new
lockdowns in certain countries the emergence of variant strains of <FONT STYLE="white-space:nowrap">COVID-19</FONT> and the potential effects of that pandemic, the severity, duration and future impact of which are highly uncertain and cannot be
predicted, and which may have a material adverse impact on the Company, including but not limited to its supply chain, third-party suppliers, project development timelines, employee base, liquidity, stock price, financial condition and costs (which
may increase) and revenue and margins (both of which may decrease). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Readers are cautioned not to place undue reliance on any of these forward-looking
statements. These forward-looking statements speak only as of the date hereof. Bausch Health undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this news release or to
reflect actual outcomes, unless required by law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">### </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>3 |</B> Page </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>bhc-20220127.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: 70.0.0 -->
<!-- Creation date: 1/27/2022 5:14:29 PM Eastern Time -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:bhc="http://www.bauschhealth.com/20220127"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:us-types="http://fasb.org/us-types/2021-01-31"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.bauschhealth.com/20220127"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
    <xsd:import schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" namespace="http://www.xbrl.org/dtr/type/2020-01-21" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" namespace="http://xbrl.sec.gov/dei/2021q4" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bhc-20220127_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bhc-20220127_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.bauschhealth.com//20220127/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>bhc-20220127_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: 70.0.0 -->
<!-- Creation date: 1/27/2022 5:14:29 PM Eastern Time -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:type="locator" xlink:label="dei_EntityAddressCountry" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCountry_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Country</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCountry_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Country</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of 12(b) Security</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>bhc-20220127_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: 70.0.0 -->
<!-- Creation date: 1/27/2022 5:14:29 PM Eastern Time -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.bauschhealth.com//20220127/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="bhc-20220127.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.bauschhealth.com//20220127/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="20.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="21.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="26.031" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="26.131" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:type="locator" xlink:label="dei_EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCountry" order="26.231" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="26.331" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="31.011" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g291411g61r84.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g291411g61r84.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M"2,"VN$18VW Y( SQ6M2K"6'A36ZN84:%2&+J56M':QOUQ'I!0 4 % !0 4
I% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140606802935288">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jan. 27, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jan. 27,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Bausch Health Companies Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">A1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-14956<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">98-0448205<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2150 St. Elz&#233;ar Blvd. West<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Laval<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">QC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">H7L&#160;4A8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">514<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">744-6792<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Shares, No Par Value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BHC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000885590<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>d291411d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="bhc-20220127.xsd" xlink:type="simple"/>
    <context id="duration_2022-01-27_to_2022-01-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885590</identifier>
        </entity>
        <period>
            <startDate>2022-01-27</startDate>
            <endDate>2022-01-27</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="duration_2022-01-27_to_2022-01-27"
      id="Hidden_dei_EntityCentralIndexKey_duration_2022-01-27_to_2022-01-27">0000885590</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="duration_2022-01-27_to_2022-01-27"
      id="Hidden_dei_AmendmentFlag_duration_2022-01-27_to_2022-01-27">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="duration_2022-01-27_to_2022-01-27">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2022-01-27_to_2022-01-27">2022-01-27</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2022-01-27_to_2022-01-27">Bausch Health Companies Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2022-01-27_to_2022-01-27">A1</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2022-01-27_to_2022-01-27">001-14956</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2022-01-27_to_2022-01-27">98-0448205</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2022-01-27_to_2022-01-27">2150 St. Elz&#xe9;ar Blvd. West</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2022-01-27_to_2022-01-27">Laval</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2022-01-27_to_2022-01-27">QC</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressCountry contextRef="duration_2022-01-27_to_2022-01-27">CA</dei:EntityAddressCountry>
    <dei:EntityAddressPostalZipCode contextRef="duration_2022-01-27_to_2022-01-27">H7L&#160;4A8</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2022-01-27_to_2022-01-27">514</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2022-01-27_to_2022-01-27">744-6792</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2022-01-27_to_2022-01-27">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2022-01-27_to_2022-01-27">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2022-01-27_to_2022-01-27">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2022-01-27_to_2022-01-27">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2022-01-27_to_2022-01-27">Common Shares, No Par Value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2022-01-27_to_2022-01-27">BHC</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2022-01-27_to_2022-01-27">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2022-01-27_to_2022-01-27">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MIR1-\SR. !9GD*88 J<11S &P %#TG1X#SY['R73>RHY_U=3_ 102P,$%
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M>FR-9V87YTC'?8Q']>5=2(6NF9MYEJ6R!F_236P@R*2*Y U+2X<L-03&IAJ
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M4')O<',O8V]R92YX;6Q02P$"% ,4    " "AACM4F5R<(Q &  "<)P  $P
M            @ ', 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    (
M *&&.U0="9944@0  .,0   8              " @0T(  !X;"]W;W)K<VAE
M971S+W-H965T,2YX;6Q02P$"% ,4    " "AACM4GZ ;\+$"  #B#   #0
M            @ &5#   >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( *&&.U27
MBKL<P    !,"   +              "  7$/  !?<F5L<R\N<F5L<U!+ 0(4
M Q0    ( *&&.U0<.&7J/P$  #P"   /              "  5H0  !X;"]W
M;W)K8F]O:RYX;6Q02P$"% ,4    " "AACM4)!Z;HJT   #X 0  &@
M        @ '&$0  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4
M    " "AACM499!YDAD!  #/ P  $P              @ &K$@  6T-O;G1E
C;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"  #U$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>122</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d291411d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bauschhealth.com//20220127/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="d291411d8k.htm">d291411d8k.htm</File>
    <File>bhc-20220127.xsd</File>
    <File>bhc-20220127_lab.xml</File>
    <File>bhc-20220127_pre.xml</File>
    <File>d291411dex991.htm</File>
    <File>d291411dex992.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d291411d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d291411d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "bhc-20220127_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "bhc-20220127_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "bhc-20220127.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 24,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 122,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "bhc",
   "nsuri": "http://www.bauschhealth.com/20220127",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d291411d8k.htm",
      "contextRef": "duration_2022-01-27_to_2022-01-27",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://www.bauschhealth.com//20220127/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d291411d8k.htm",
      "contextRef": "duration_2022-01-27_to_2022-01-27",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bauschhealth.com//20220127/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bauschhealth.com//20220127/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bauschhealth.com//20220127/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bauschhealth.com//20220127/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bauschhealth.com//20220127/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bauschhealth.com//20220127/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country",
        "terseLabel": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bauschhealth.com//20220127/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bauschhealth.com//20220127/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bauschhealth.com//20220127/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bauschhealth.com//20220127/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bauschhealth.com//20220127/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bauschhealth.com//20220127/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bauschhealth.com//20220127/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bauschhealth.com//20220127/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bauschhealth.com//20220127/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bauschhealth.com//20220127/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bauschhealth.com//20220127/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bauschhealth.com//20220127/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bauschhealth.com//20220127/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bauschhealth.com//20220127/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bauschhealth.com//20220127/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bauschhealth.com//20220127/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bauschhealth.com//20220127/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001193125-22-019895-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-22-019895-xbrl.zip
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MC4Q6.[G>:7=\M56-'OOX%U!+ P04    " "AACM4Q-#QR'P&  #B1@  %
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MQ[7:TK^T)=W%DU]=HO;\!U!+ P04    " "AACM4N!QM&[H$  !^+   %
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MMI,(F'6]:1+Y-IBQ]/U(Q_E\2ARU6>@K0))T0<%#0:Y+"Z&'#U-9[3M=4!#
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M@91+$/^>9T4<9ZA6>+=LW=IQ&4.T-#;#UG1"%#UZB5G6U9==V:ME=>$4JXG
MY@F@\2:=\J-O?WNB^E+:,VH1_>(4(CO4;M91@MD<3OF-MEI;7V#5?BVW2Z>X
M;?<-;E(0<ST&?Q5\I1(]WR\P.W&[ZT"(^E)\U?8.YIE;S[ALN]37&1&8#O0M
M>OT;G(BQ)*X[P))AB\ZMW92>7ES%9H%U2_'\6&1[HOJBVC-J$?T/C[-<!:5D
MW.D"\T#M]HQY,8^'ZI)_ %!+ P04    " "AACM4YAU\PAT1  #H:   #@
M &0R.3$T,3%D.&LN:'1M[3UK4QNYEM^W:O^#RMG,);5^M3$!F\<MXI ;;A)@
M,7-G=K],R=VRK9MVJT=2@SV_?L^1^FFWL1T,9#)0E>"V7D?GI?-2<_3WZ<0G
MMTPJ+H+CBE-O5@@+7.'Q8'1<B?2P=E A?S_YS_\X&FOH")T#U?6TK.E9R-1Q
M9:QUV&TT[N[NZM.!].M"CAK0W,#F1JO9:M::3JWE5.*14Y\'7PNC[G;-&*?3
MZ31,:])UH6<Z?ZO9W&U@\X JEG0?C-U"[P&-E#L>,^KK<=T5$P2FU71:^RDH
MBI<! I,[C5^_?.Z[8S:A-1XH30,W72;2<BE0G0:T)AVY$NV6LW_/#N(>Z8#I
MLKX.] U@O^S7=]>?L^ZZO'_6M:$E#=10R G50-V8'*V:T\I-4E.LB#AXKH_$
M[;WS.'NUYD%M-R,K+,[OV^H<%K'5RP;D.[]MV,:DJ\?F^B7P00/NR/F]G=)&
MS7'ED*J!F3=I,0.0(S/0E=3+1J5-B\.6LS"*2<7("Z,>_M9<^^SDH/;IJ&$_
MPG<3IBG!&6KL]XC?'E=Z(M LT+4;6*Y"7/MT7-%LJAMF1M+ <8UX4D+(T4!X
MLY,CC]\2I6<^.ZYX7(4^G74#$;#*"3GBTRYV9S+^S#V/!?8S=+F()DQREW#O
MN/+1-/T&&/WM+  @9SU875+_//#8]!.;_>9%TI#^-Q0B(]'[OVF1>ZJ0@$X0
M!L:[I5/$FYKJ:S:$;BOG.VG"S\'!WEZG>=0H0+QJ!Z<3%GCP3W_PZ6@SR M#
M-X9X2'W%%H%MS.%>LB&3H&*9@F?48EUE5 TL0XP"["+/'5<4GX0^2HSY;BP1
M"E!RM42/U:?*2UJI=*5 'EA;73Z"(CXY:A2W$V^^L&'SK$0D[:-1'-T8T8:2
M:R Z&<8,HZ6/W,,OAIQ)8D!@I6JM=_ZIR%SS@Q'JTOE#(*CPTD?0:%*_IYJ=
M9+ E([.V#%9O2=^D)5TV7:=1P$Z*S0Q[C;R(-T 5P*^<0L!1->KS4=!U82],
M5HKM=]S3X^Y!?8\'A[F^/AOJPPF5(Q[4\'.7T$B+Y!O)1^/X*YPN3";#PZ(V
M9J85K(@PG4*+L)M[' BMQ<1\,Q 20$^^<<(I4<+G'GG5-#^5DY]>.6^;AT>-
M<-E"NZL7:GWS0KEIVS )6=P &0)I:HK_P;K.0?H\I!/NS[HW?,(4N6!WY%I,
M:'!HVNXLW /A>X<EY.F?]7Z^/K\Y/^N3TXOWY.S7WL?3BW^<D=[EER_G_?[Y
MY<5R&)NK86QM \9?J!J#<:A%4"7OZ[TZ:37WVITYN'*+KL,*10JL8N%25GC[
M3:Q0;T*W(C<<6K%H.:\7=[^F6&2;2:2RC&#.&A3;"E=]N+S^,G]H9H?>>^%&
M>.;E3(_USSQCUA1/O!=.>!1.V(KL@G:Y/KNX(==G5Y?7-\^O2ZXBJ2(::*(%
MZ3,7F8TXNT1(XNSM>&^>'T Q)'K,$+9(<LUA_-G4'=-@Q,BIJPDT.YW=]G(X
MGXRR:$(@.-<L%%*3G>09H6<4S BF-&&WT)M(TX5Y;[JKE<*5L47.K(FRJ78@
MUF4\KH";V?5@@MH$QH]QE9I'9[49 %9C0>7DGS2(J)R1UGZ5X/@7E?(4*J75
MW@;CS;'0AAPR[S5>LQ%7&&[0%]!2.7EGHCCDHPGCD)Z8A#1 *3P/W/H*+ME,
M6S2W@8N=LRD%K8"@6UE,-D.H(OV0N>A@>(0'Y%PKTAN#D\#DO)9[X>XEW/T0
MQ& <A@Y\1ESF^RJDK@EO-BOF.:2>ESS':\5[=87OTU"Q;O+A?A[),10:;A8;
M3K/Y.L9=MQF#V6TF#A0")NTOK^B7[;9?HTNM;1 I;;QE4G.7^C%R[7[+.L:S
MM-:?)0&X=,3\=/!?#+=,NH1TQ&H#R>A7#)N"1]VEMP*X8VVD.89LA65)CI%(
M@9.ZAH?(W$Z '0! H'!08)N<X&Y;98$J$A).5#.NK^&8ZXDHT'+6$QXKG($8
M:NTR;T1E*,6M:WOA^?<.;0N%^LV/)@-.YS5;E?1H0#WX'C>V/E,D C#?_?M'
MZ@?N,YAJ@%JK"7V<=F?O[:+"_ZN@XX9.S^, E6O&)KCI'-2:[?8!N.#W(><Q
M9/5@2Z+Z;>?U5OSB'2.MZ&U<@IDLR3_!QE<>MVZ(&)I#:$WPG$< KZ!8#)1R
M!-;/'^;YC3TBGX7SGY-D8 ).N,)DY7.3!U44L7+X5R7&>?VZWJ^3LTGHBQF3
MSTV1HHI<H(W5@O _&H(/\->WXBIL]WPX]3S)E(I_?0;;WJF<M)R])NEKH(__
MQT^O6KN[AU22=_ZM5R>_,*6_/_?I47#2@X^7\D;<@9WUF=Y2?]&X>I1US=ER
M*:_ TN,F\SUO""KL@(8@3H!6X/]$;,#<[YXLR_!LS=F'Q(@,6F*S.$%*8OC>
MGP)> M.5 "3[_\=#:XIO&-O^N/_9JNKVZ<$VJ;(=W1MO$>,,5Q(XC(?4)V=3
MYD::WS)R.00]R-2;'=@]P>W?$TQ]+J6740V%]!2,T6^BTY[3GB=/;>E*GP4<
MH%=C$23NQ::K[;?;M;?[G54QRF?@B"S<]-.K@Y:S?ZC HO!9B)LE@=EME0"G
M^!%&.P@%?,/F'\H9VX'] V@!L, #$SF31BG ([4\#E /B8VZ@[&$VI3X5"6!
M[)?XV>,DG%9)/.CF,7._F@P##>$@"R5'=VH@IF3 ?'&'5,-&I"TYJ'TB0^XC
MXW$%7*A9X $UM0""3B)?TX")2/DSHD  U7!F1L8#Q #P$'M!=DJ9158CF <X
M)9@E;4/AP^(X#@]7CJZ"ZB[ED;??'$G<5J30R4HANLU<S' Q-CD7NUS/HZ^4
MA?$PM+C,#;$]]EX?EKH;6S*5?I%< PN@-Q<%L<&N%HV!@1#^@ (]-7 5@MP!
M]7NXJ'I7>%YSGA(I$IP\^.R;*YZIG,3; _SD]T?"7+KS.@(>:K?V8@:>RS)B
M<G''V2>]#]>DM=NL0\<U')D7MGYFMNZ#-G>!@L'H"ZA"T(?^C\/3V=Y@:KNY
M189VVK3FM'(\74B7IQS=;M9MSQ>F_OZ9^DHRU--8P6GJA/#DEN!?H/'\HS W
M[+'FYC:Y4G,[;:_6VAF\68_5;=\79O_3,?NY4A&3+RQO6'Z7U=H[[GHL'_=]
M^N@K'%29&67]!";!TPC+2LV,!,=^ VQAN9OP4G'P8U8<?$,6<PTW?LE>QURS
M&K(" \UP)^D&Z9O'2)?<X&TDY'Y&W3%Q?:K4T^2QOA6#SYOMNI$49?:YDUS]
MV02:=M03Y1S_G+1**O ,9[/XD'INRL&! RH  ,I.I;G3\4>HILHYP_8<GCFM
M@5$U&X?:T1 #I/7'5#)5)1>"7%%)_D7]:.&:W9^H%"A#4*Q1K$1OC)UW'WL_
M!!82-DEL25/X^] L(LI\DD)$X?A?(;^2OA;NU]1F7<P#WP@)JXJ%?O.%5$]A
MQ)X''EKBC QFQ#5Q=ICQ*R@09DJ5YH+@7!' /9CQN.B(C*2XTV,TZ$,,C%-%
M/#;D@2T]MH''YAY9O-N076G8)3O('/N')OB8=(9E "<A%BUCEL9Z!:U!K54R
M5]D]B712]!"R<;EIZX^<I<PQMDF;5$[.EB!MNT4!R2K_,(O8.O;9M_N2CXDC
MX+WA/=R$*<12UN0+J9DQ,![SP=<"Q@N$\;PBQ>R5E&F2 ,)7"W#CC=E[KX@3
MLY8_P\7O."R-] @ /FB1[)8K& ?L3 ,78Y#4-24#V!E?,N!1Z2F;^O&6N7V[
M.S1U^_)\6B<IQK>74OS1;LC:O.)\=O%O.7-EP("&8*[X=W2F_A:SZS@U;,"S
M%;+[JF-^#A,XPVDAQ-1XQJO,CUQC P*FV<0B]*#>=.+JTS.\G*7N48!OE\"2
MWU_[]8:ROGAJF\]=K@&#;AQ, 3FZ$!H&FA 82EIZ*&X*K"$.:!#8Z^; 7@8D
MOBIFL9?<%ZN2^^X)D1V4<ZR):#4/8]5KGIS#-Z!: M >+FJB,86#5!.?PO,8
MO@!= GJ$N^8CJ(MXZZ W_@O$UT(PX+Z/*H6.1J#X4"F&:3$.G:!>POZHNQ0+
M..@O%>,S,/CT(H8;V"^ :%"= %@G-]!BL7\'BY$! QL8\^<2;_0!R)3(^*[?
M6SA4]UZC'B5XM:YJ=H 3I[";[1@-J[-904N#S(%GUWR=*,6%32"',C$L@<9.
M;DT+'/ISP%'?F_(WA5KW]P@X*;[WI. LC% 'P\P\N(4="%D:7&^?+L^+QA9*
M%>T:.K''2!Y_Q>X)(BTV1*31E2J'M" +9=$:.(-K/]?[]9C[$=-J(53*1I%O
MBQ7Z2_=PGYG3>@S)Z?E"Q<R;43YE"T-*/*&!G&#H>.8\!M1$H0CL6<SRU1<<
M$&>S?P/0$=DT.S$!SJ\N4_F"(;%L_C?Y+"8#D,VLICT94.@1#S7D4A%\G<Q?
M)3DB%R?-K5@E@T@GQLA"+^()V#AN5;A $&(+ZX'=420$.8U&D=)6M)V]1+G@
M3+'>2+E>XHM[I*U@@5^,37*(!:DTD&L@0RRBT&426C/'R"!#L<#!!J&898@;
M"A0*_4BA@2.C6!]%04BYE\K_D_/130X5U%?"@HYZ$FL1)5A[5+'2W,&>NURB
M81PU!ER,C[RN39%1!V5NC#WIX:NDK&683K[CO5DZ?Q5X..2&X6/M5@"62B22
MID;IHYX#*"@Z,&,^X%J13J?N&.3#AY8%$3R67B0E9DWB"]= 6%/GM%*''-0^
M51/]8<-!N#Y/[WK$,( V!?,Z?77.LQ :K;B1B$NV,C6>ARNAV!Q*S5E:P.L+
M0A^XQV2+R9D^S\1K,[ GC/X#/6]/8Y9:-Z8:CX%^B^T#92L^TLJ[?+]!9$KT
MP)U3J:Q586*P<,;@P%J# 16EK<P;8NUI<3[H2?U$WQ7F05,"A_T[?Q^+)]'3
M[$Q8,N.=B'P/EXX"G]X-(]]8+<45\B=>+DFXW.:P)8:F9C\_#RR H1>OBHLA
M093(S5<%+IHERR1V$H()7D"YO<2F+@MU07^B*SY-#H^A%)."FVV^C0\CS.*J
M)6$=)#\-0T!77"-0LI&\=3>FMRR&G 5F=!YEF3(8)EA/%(&U"4#4P 57(7C<
M<(+%-9K9\J:JGR//EZ'2*GG0._ZLFO&/-0@REIEC&'M1(#V?)Q2L/#3,R8 J
MD#S+.US%N,P0F0-S'HV&T^9Q].(";]D%[J +_"$-YQA!L"1 @B=*[(D]330G
MEBR=FZ?UW1<%F*UN6A5@8]UD[?3]7I*A+RLJZ#Q^_IX\9P+__JQ'S$-' PGB
M;&^<Y/,):^ XX9]<KN:)]KN!0GB,=.E[IES)S;%W7YHTQ^N+O)!<T,"6$M3E
MFL$>0H$,CBNM1W_!Q;U4!PR7,AH:<5OCF=+\'27V):->J^.T'<=CTT['J8_U
MQ-2*9<9F$C,S#MN8Q0&S\M!"E7C& B\-VY&C!GVA*]CD3T_7UAITQ7C$TIC1
M"V%7$=9IMA^5KFBKNP):".XR,6BWY$C;Q*2.7U9EW@1.\%7@]0S321;\Q1A^
MA)NR?7B@.@+Q?.HX1?Z5C-;1O->W+$OS5\L2P5[DSXA+(V52+5S%MS=-+ %\
M.=@O^L;@Y\,R S:F_A"=2)S(>(]Q!XPJ1%BC8:8#2HV%A(UY\^&<AQCI1X:3
MG]-4;R]:ZI9=5Y;P[I>;XFL5WY;-Y[2V/.%^Y_%?(+92=V9GQ]Y*"_[=Z<_]
MWD?R\>ST\\U'?!'SU>D%OI_Y_*)77_&.I75..F3/^XXZTY[!VWY^Y)V\FW4W
M/=CR_=.][%96<%/)&;691[*BJF%#S=A0#=*G$W+F>V UB>CK[ G*-]>P[QY
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M8 DR^*M>_^#P1_%HL>^NBGF'5>]QX^H#G-MT*E@F[3;VN!RDU0ZFW?JG-4K
M,75=LS4:G?3V47=]7B,WKC$ BW2P*=BEE^DGPK/2_;:9JHJVPT+O:IZ@A=LM
MG"=<IHS>B2(OA]ZASD/#SDE>$!EEOD\H6B7FP%9RN6DN4XE L'ZK)&/3NI,R
M^1@$4<N4<CWE8W9@-SU.C2#GMRG= G*[M41DJZ4SD<NY-M?2FT*6(@M3Y@;
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M!/^A0NZ>L&(I2I0MZV)9L;K0EF;5DE>BW=/[5@2*9+5!%!H%B,V)_?@]F54
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MD<H*8;$04F>FX4Y)/HQTL(@-'YA7'V\+43'!A^F_08?I$&>>)B:5O%H]CMV
MQJF5:U=/K+YB93<V#!UT)$F-4 TSL=!P.&_(\G+=DA<T\?V2$WSO8!EPK)I
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M^!<574E%7SV;BF+8[<5O>,C_![K_ 5!+ 0(4 Q0    ( *&&.U1(UPI0# ,
M  H*   0              "  0    !B:&,M,C R,C Q,C<N>'-D4$L! A0#
M%     @ H88[5,30\<A\!@  XD8  !0              ( !.@,  &)H8RTR
M,#(R,#$R-U]L86(N>&UL4$L! A0#%     @ H88[5+@<;1NZ!   ?BP  !0
M             ( !Z D  &)H8RTR,#(R,#$R-U]P<F4N>&UL4$L! A0#%
M  @ H88[5.8=?,(=$0  Z&@   X              ( !U X  &0R.3$T,3%D
M.&LN:'1M4$L! A0#%     @ H88[5(/J=5?A$   ,S@  !$
M ( !'2   &0R.3$T,3%D97@Y.3$N:'1M4$L! A0#%     @ H88[5/$1$-2E
M$   1S<  !$              ( !+3$  &0R.3$T,3%D97@Y.3(N:'1M4$L%
3!@     &  8 ? $   %"      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
